MyAverix Finance
NS · Pharmaceuticals
Haleos Labs Ltd (HALEOSLABS)
Pharmaceuticals & Biotechnology
Haleos Labs Ltd (HALEOSLABS) is listed on NS in the Pharmaceuticals sector. Industry: Pharmaceuticals & Biotechnology. As of 2026-07-10, reported market cap is $4.15B, P/E ratio is 23.34, net margin is 5.5%, dividend yield is 0.11%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for HALEOSLABS
Haleos Labs Ltd (HALEOSLABS) — FAQ
What is Haleos Labs Ltd's market cap?
Haleos Labs Ltd (HALEOSLABS) has a reported market cap of $4.15B (data as of 2026-07-10).
What is HALEOSLABS's P/E ratio?
The price-to-earnings (P/E) ratio for Haleos Labs Ltd (HALEOSLABS) is 23.34 (data as of 2026-07-10).
Does Haleos Labs Ltd pay a dividend?
Haleos Labs Ltd (HALEOSLABS) shows a reported dividend yield of 0.11%. Open the MyAverix Finance app for dividend history and payout details (data as of 2026-07-10).
What sector is Haleos Labs Ltd in?
Haleos Labs Ltd (HALEOSLABS) is classified in the Pharmaceuticals sector (Pharmaceuticals & Biotechnology industry).
What exchange is HALEOSLABS listed on?
HALEOSLABS is listed on NS.
What is Haleos Labs Ltd's net margin?
Haleos Labs Ltd (HALEOSLABS) reports a net margin of 5.5% (data as of 2026-07-10).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.